InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Thursday, 04/20/2017 4:27:17 PM

Thursday, April 20, 2017 4:27:17 PM

Post# of 2099
So does this positive DSMC review mean there was no lack of efficacy? hmmmmm

============
I. REVIEW OF INTERIM ANALYSES
Clinical research study/ies that are monitored by the DSMC may contain stopping rules for excessive toxicity or lack of efficacy. Whenever an interim analysis is performed to ensure that no study defined stopping rules have been met, a copy of the analysis must be forwarded to the DSMC. The DSMC will acknowledge the receipt of the analysis and discuss the results at its next regularly scheduled meeting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News